INGN
Inogen, Inc.NASDAQHealthcare$6.21-0.96%ClosedMarket Cap: $169.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.90
P/S
0.50
EV/EBITDA
-21.18
DCF Value
$-6.55
FCF Yield
-12.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
47.6%
Operating Margin
-8.7%
Net Margin
-6.5%
ROE
-11.6%
ROA
-7.6%
ROIC
-12.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $81.7M | 50.4% | $-9.3M | $-7.1M | $-0.26 | — |
| FY 2025 | $348.7M | 47.6% | $-30.2M | $-22.7M | $-0.85 | — |
| Q3 2025 | $92.4M | 50.8% | $-7.1M | $-5.3M | $-0.20 | — |
| Q2 2025 | $92.3M | 44.8% | $-6.1M | $-4.2M | $-0.15 | — |
| Q1 2025 | $82.3M | 44.2% | $-7.7M | $-6.2M | $-0.25 | — |
| Q4 2024 | $80.1M | 45.3% | $-11.4M | $-9.8M | $-0.41 | — |
| FY 2024 | $335.7M | 46.1% | $-42.5M | $-35.9M | $-1.52 | — |
| Q3 2024 | $88.8M | 46.5% | $-7.8M | $-6.0M | $-0.25 | — |
| Q2 2024 | $88.8M | 48.1% | $-7.1M | $-5.6M | $-0.24 | — |
| Q1 2024 | $78.0M | 44.1% | $-16.3M | $-14.6M | $-0.62 | — |
| Q4 2023 | $75.9M | 37.1% | $-29.0M | $-26.6M | $-1.14 | — |
| FY 2023 | $315.7M | 40.1% | $-109.4M | $-102.4M | $-4.42 | — |